Literature DB >> 6124555

Somatostatin: a paracrine contribution to hypothyroidism in Hashimoto's thyroiditis.

A P Dhillon, J Rode, A Leathem, L Papadaki.   

Abstract

Thyroid tissue from 18 consecutive cases of Hashimoto's thyroiditis treated surgically were stained immunohistochemically for neurone specific enolase (NSE), somatostatin, calcitonin and thyroglobulin. Cells staining for NSE and somatostatin were present in 14 cases. In four cases large numbers of cells including oxyphil cells stained for NSE. Consecutive sections showed an identical staining pattern of these cells for somatostatin. Sections stained for calcitonin showed few or no positively staining cells. There were moderate numbers of NSE and somatostatin-containing cells in five of the cases, occasional cells in five and none in four cases. Electron microscopy confirmed neurosecretory-like granules within positively staining cells. Somatostatin is known to inhibit T3 and T4 production or release from thyroid cells by a direct action. We suggest, in Hashimoto's disease, somatostatin in paracrine cells serves as a local inhibitory neuroendocrine effector and could be causally related to the hypothyroid state.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124555      PMCID: PMC497775          DOI: 10.1136/jcp.35.7.764

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  ABNORMALITIES OF IODINE METABOLISM IN EUTHYROID, NONGOITROUS WOMEN WITH COMPLEMENT-FIXING ANTIMICROSOMAL THYROID AUTO-ANTIBODIES.

Authors:  W W BUCHANAN; R M HARDEN; D A KOUTRAS; K G GRAY
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

2.  Defective organic binding of iodine by the thyroid in Hashimoto's thyroiditis.

Authors:  M E MORGANS; W R TROTTER
Journal:  Lancet       Date:  1957-03-16       Impact factor: 79.321

3.  Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.

Authors:  D Schmechel; P J Marangos; M Brightman
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

4.  Single cellular origin of somatostatin and calcitonin in the rat thyroid gland.

Authors:  S Van Noorden; J M Polak; A G Pearse
Journal:  Histochemistry       Date:  1977-08-22

5.  Immunohistochemical demonstration of somatostatin-containing cells in the human, dog and rat thyroids.

Authors:  Y Yamada; S Ito; Y Matsubara; S Kobayashi
Journal:  Tohoku J Exp Med       Date:  1977-05       Impact factor: 1.848

6.  Increased plasma and tumor somatostatin-like immunoreactivity in medullary thyroid carcinoma and small cell lung cancer.

Authors:  B A Roos; A W Lindall; J Ells; R Elde; P W Lambert; R S Birnbaum
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

7.  Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin.

Authors:  U Loos; S Raptis; J Birk; F Escobar-Jimenez; G Meyer; G Rothenbuchner; E F Pfeiffer
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

Review 8.  Calcitonin: physiology and pathophysiology.

Authors:  L A Austin; H Heath
Journal:  N Engl J Med       Date:  1981-01-29       Impact factor: 91.245

9.  Struma lymphomatosa: primary thyroid failure with compensatory thyroid enlargement.

Authors:  P G SKILLERN; G CRILE; E P MCCULLAGH; J B HAZARD; L A LEWIS; H BROWN
Journal:  J Clin Endocrinol Metab       Date:  1956-01       Impact factor: 5.958

Review 10.  The diffuse neuroendocrine system and the apud concept: related "endocrine" peptides in brain, intestine, pituitary, placenta, and anuran cutaneous glands.

Authors:  A G Pearse
Journal:  Med Biol       Date:  1977-06
View more
  3 in total

1.  C cells evolve at the same rhythm as follicular cells when thyroidal status changes in rats.

Authors:  Inés Martín-Lacave; María J Borrero; José C Utrilla; José M Fernández-Santos; Manuel de Miguel; Jesús Morillo; Juan M Guerrero; Rocío García-Marín; Esperanza Conde
Journal:  J Anat       Date:  2009-03       Impact factor: 2.610

2.  Somatostatin inhibits rat hepatic T4-5'-deiodinase. The effect is independent of the associated hypoinsulinemia.

Authors:  L A Gavin; M Moeller
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

3.  Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease.

Authors:  Aaron Lerner; Polina Sobolevskaia; Leonid Churilov; Yehuda Shoenfeld
Journal:  J Transl Autoimmun       Date:  2021-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.